… A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe
… We identified a survival benefit among adult patients with GN-BSI receiving EI-BL compared …

… Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam plus macrolide
combination therapy as first-line options for hospitalized adults with mild to moderate …

… ) hospitalized during 3 separate years reported that β-lactam … in adults of all ages also
reported that various β-lactam plus … -term mortality compared with β-lactam monotherapy. Only a …

… option for hospitalized patients with community-acquired pneumonia (CAP) has not been
defined. The effectiveness of β-lactam/fluoroquinolone (BLFQ) versus β-lactam/macrolide (BLM…

… suggested [30], but in older adults, significantly increased risk of adverse events … lactam
antibiotics do not provide predictable trough antibiotic concentrations in older adults hospitalized …

… Guidelines recommend dual-therapy consisting of a β-lactam/macrolide (BLM) for hospitalized
patients with community-acquired pneumonia. Nevertheless, the superiority over β-lactam…

… and EBR among hospitalized adult patients with P … adult hospitalized patients were CR.
More alarmingly, nearly 10% of P aeruginosa infections were resistant to most of the β-lactam …

… A retrospective analysis was conducted on adult inpatients with a β-lactam allergy who …
The primary outcome was overall antibiotic cost savings for patients switched to a β-lactam …

… noninferiority of β-lactam monotherapy in patients hospitalized for … β-lactam monotherapy
was noninferior to the combination of a β-lactam and a macrolide in adult patients hospitalized …

… used antibiotics among adult, hospitalized patients with … hospitalized adult patients
with CR-GNIs who received targeted treatment with a newer β-lactam or β-lactam/β-lactamase …